TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 98 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q4 2018. The put-call ratio across all filers is 0.60 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $21,244,000 | -9.6% | 1,076,742 | -21.2% | 1.24% | +14.4% |
Q3 2019 | $23,501,000 | -24.1% | 1,366,325 | -21.9% | 1.08% | -14.8% |
Q2 2019 | $30,960,000 | +4.0% | 1,749,147 | +16.8% | 1.27% | +2.0% |
Q1 2019 | $29,755,000 | +729.3% | 1,497,934 | +602.1% | 1.24% | +288.1% |
Q4 2018 | $3,588,000 | – | 213,337 | – | 0.32% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TFG Asset Management GP Ltd | 1,903,662 | $29,449,652 | 5.37% |
MANAGED ASSET PORTFOLIOS, LLC | 1,736,416 | $26,862,356 | 4.12% |
Y.D. More Investments Ltd | 1,381,550 | $21,372,579 | 4.11% |
Clean Yield Group | 533,157 | $8,167,965 | 3.62% |
XY Capital Ltd | 143,697 | $2,222,993 | 1.28% |
Mondrian Investment Partners LTD | 4,081,715 | $61,225,725 | 1.26% |
Capricorn Fund Managers Ltd | 204,892 | $3,169,679 | 1.10% |
Legacy Wealth Asset Management, LLC | 124,967 | $1,933,239 | 0.71% |
HAP Trading, LLC | 263,679 | $4,079,114 | 0.65% |
BRANDES INVESTMENT PARTNERS, LP | 1,802,036 | $27,877,493 | 0.54% |